0000899243-20-025707.txt : 20200918 0000899243-20-025707.hdr.sgml : 20200918 20200918161457 ACCESSION NUMBER: 0000899243-20-025707 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200918 FILED AS OF DATE: 20200918 DATE AS OF CHANGE: 20200918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Donaldson Michael Paul CENTRAL INDEX KEY: 0001824022 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 201184160 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-514-7149 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-09-18 0 0001599298 Summit Therapeutics Inc. SMMT 0001824022 Donaldson Michael Paul C/O SUMMIT THERAPEUTICS INC., ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 3.52 2030-06-08 Common Stock 600000 D The option was granted on June 8, 2020. 300,000 shares underlying the option are scheduled to vest quarterly over the period beginning on the date of grant, with (i) 23,489 shares vesting on September 30, 2020, (ii) 18,750 shares vesting on the last calendar day of each of the fourteen calendar quarters following September 30, 2020 and (iii) 14,011 shares vesting on June 30, 2024. The remaining 300,000 shares underlying the option are scheduled to vest quarterly over the period beginning on the date of grant, with (i) 23,489 shares vesting September 30, 2020, (ii) 18,750 shares vesting on the last calendar day of each of the fourteen calendar quarters following September 30, 2020 and (iii) 14,011 shares vesting on June 30, 2024, in each case, subject to the satisfaction of certain performance conditions. /s/ Michael Paul Donaldson 2020-09-18